CT scan to predict liver failure after surgery
Part of Cancer, Digestive system clinical trials.
This trial uses special CT scans to create a map of your liver's blood vessels before surgery. The goal is to predict if your liver might fail after part of it is removed, so doctors can better plan your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are scheduled to have a major liver resection (removing at least 3 sections of your liver).
- You have a recent CT scan of your liver with contrast dye, which will be reviewed by the study team.
- You agree to have follow-up visits and blood tests for at least 30 days after your surgery.
- You do not have a known blood vessel problem in your liver (like a clot).
- Your surgery is not an emergency procedure for injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well imaging predicts the outcome of surgery for liver metastases from colorectal or breast cancer. If you are having surgery to remove liver metastases, you may be able to participate.
This study looks at whether special scans can help doctors better predict how aggressive a person's liver cancer (hepatocellular carcinoma) will be, especially right after surgery. If you are planning to have surgery to remove the tumor as your first treatment, this trial might be a good fit.
This trial uses a special scan to predict liver problems after surgery or ablation for liver tumors. It aims to help doctors personalize care and avoid complications.
This trial uses CT scans to measure the volume of liver tumors in people with hepatocellular carcinoma (HCC) who cannot have surgery. The goal is to see if this measurement helps guide treatment with TACE, a procedure that blocks blood flow to the tumor.
This study uses artificial intelligence to analyze CT scans before and during liver surgery. It aims to build a decision-making system to help doctors better plan and perform surgery for liver cancer or other growths.
This trial studies how a whole-body PET/CT scan using a “tracer” called 18F-FDG can help decide which people with liver cancer (HCC) may benefit from a liver transplant. It may help the transplant team better sort out who is likely to do well after transplant.
Hear when a new Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.